Poojith Nuthalapati
Associate Research ScientistAbout
Research
Publications
Featured Publications
Examining psychiatric and cognitive adverse effects of brivaracetam, clobazam, lacosamide, eslicarbazepine, and perampanel in a veteran population
Nuthalapati P, DeBonis D, Gopaul M, Okafor C, Orner M, Jimenez A, Altalib H. Examining psychiatric and cognitive adverse effects of brivaracetam, clobazam, lacosamide, eslicarbazepine, and perampanel in a veteran population. Epilepsy & Behavior 2025, 172: 110557. PMID: 40570732, DOI: 10.1016/j.yebeh.2025.110557.Peer-Reviewed Original ResearchInterventional Brain Medicine: Medicine's newest frontier
Nuthalapati P, Palmer C, Barbosa D, George M, Brown J. Interventional Brain Medicine: Medicine's newest frontier. Brain Medicine 2024, 1: 3-5. DOI: 10.61373/bm024g.0013.Commentaries, Editorials and LettersImproving Seizure Frequency Documentation and Classification
Nuthalapati P, Thomas L, Donahue M, Moura L, DeStefano S, Simpson J, Buchhalter J, Fureman B, Pellinen J. Improving Seizure Frequency Documentation and Classification. Neurology Clinical Practice 2023, 13: e200212. PMID: 37873534, PMCID: PMC10586801, DOI: 10.1212/cpj.0000000000200212.Peer-Reviewed Original ResearchAn analysis of structural, spectroscopic, quantum chemical and in silico studies of ethyl 3-[(pyridin-2-yl)amino]propanoate: A potential thrombin inhibitor
Poojith N, Rani N, Potla K, Rose J, Suchetan P, Pillai R, Vankayalapati S. An analysis of structural, spectroscopic, quantum chemical and in silico studies of ethyl 3-[(pyridin-2-yl)amino]propanoate: A potential thrombin inhibitor. Journal Of Molecular Structure 2021, 1226: 129378. DOI: 10.1016/j.molstruc.2020.129378.Peer-Reviewed Original ResearchStructural, spectroscopic, and in silico studies of 3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol: A potential antidepressant agent
Poojith N, Kigga M, Rose J, Potla K, Vankayalapati S, Chinnam S, Adimoole S, Pillai R. Structural, spectroscopic, and in silico studies of 3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol: A potential antidepressant agent. Journal Of Molecular Structure 2022, 1250: 131859. DOI: 10.1016/j.molstruc.2021.131859.Peer-Reviewed Original Research
2026
Predictors of Emergency Care Utilization in Veterans with Psychogenic Nonepileptic Seizures (PNES) (P1-11.004)
Hossameldin S, Nuthalapati P, Gopaul M, Altalib H. Predictors of Emergency Care Utilization in Veterans with Psychogenic Nonepileptic Seizures (PNES) (P1-11.004). Neurology 2026, 106 DOI: 10.1212/wnl.0000000000217602.Peer-Reviewed Original ResearchGlymphatic system dysfunction in epilepsy: a systematic review and meta-analysis
Raj R, Sharma A, Singhal A, Kansal B, Agarwal A, Bathla G, Nuthalapati P, Duggal A, Ali M. Glymphatic system dysfunction in epilepsy: a systematic review and meta-analysis. Epilepsy & Behavior 2026, 183: 111141. PMID: 42250499, DOI: 10.1016/j.yebeh.2026.111141.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsBurden of headache among people with epilepsy: A systematic review and meta-analysis
Sharma A, Paruchuri A, Kola P, P N, Pal A, Agarwal H, Tiwari H, Nuthalapati P, Beriwal N, Kansal B, Garg R, Malhotra H, Singh A, Singh M, Suresh V. Burden of headache among people with epilepsy: A systematic review and meta-analysis. Seizure 2026, 138: 71-83. PMID: 41990684, DOI: 10.1016/j.seizure.2026.02.015.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCenobamate beyond Epilepsy: exploring associations with vascular risk factors through serological markers
Jimenez A, Zhou X, Agadzhanian N, Hanin A, Toghramadjian I, Okafor C, Nuthalapati P, Tallapalli J, Sakya S, Singh A, Altalib H, Mattson R, Schoenfeld M, Herlopian A. Cenobamate beyond Epilepsy: exploring associations with vascular risk factors through serological markers. Epilepsy & Behavior 2026, 176: 110890. PMID: 41616663, DOI: 10.1016/j.yebeh.2026.110890.Peer-Reviewed Original ResearchStudy protocol for a prospective, cluster randomised control, hybrid type 1 effectiveness-implementation trial to evaluate the Reduction Of Seizures through Education and Support: the ROSES study
Altalib H, Nuthalapati P, Ali S, Gopaul M, Okafor C, Gaglio B, Herbst A, Dewain S, Hossameldin S, Speranza F, Deep P, Fischbein K, Hirsch L, Pugh M, Clary H. Study protocol for a prospective, cluster randomised control, hybrid type 1 effectiveness-implementation trial to evaluate the Reduction Of Seizures through Education and Support: the ROSES study. BMJ Neurology Open 2026, 8: e001467. PMID: 42367638, PMCID: PMC13295823, DOI: 10.1136/bmjno-2025-001467.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Get In Touch
Contacts
Mailing Address
Yale School of Medicine
2 Church St South
New Haven, Connecticut 06519
United States